本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

iTeos Therapeutics

7.16
-0.1950-2.65%
成交量:27.95万
成交额:203.09万
市值:2.73亿
市盈率:-2.15
高:7.37
开:7.31
低:7.16
收:7.35
数据加载中...
2024/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/20

重要事件披露

Form 8-K - Current report
2023/05/17

SEC问询函

Form CORRESP - Correspondence
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals